期刊文献+

凝血酶原复合物在围术期稀释性凝血障碍中的应用 被引量:3

Prothrombin complex concentrates treated for perioperative dilutional coagulopathy
原文传递
导出
摘要 目的:探讨凝血酶原复合物在围术期稀释性凝血障碍中的临床应用。方法:收集最新发表的相关文章,对凝血酶原复合物的药理特性、临床试验进行分析总结。结果:围术期稀释性凝血障碍是围术期出血的重要原因,是外科患者严重的并发症之一。凝血酶原复合物可迅速、高效补充凝血因子,改善患者凝血功能,减少出血。尽管其为血液制品,但病毒安全性可靠,且血栓风险低。结论:凝血酶原复合物治疗围术期稀释性凝血障碍安全有效。 Objective:To review the use of prothrombin complex concentrates in the treatment of perioperative dilutional coagulopathy.Methods:Analyze and summarize the latest researches related to the use of prothrombin complex concentrates in the treatment of perioperative dilutional coagulopathy.Results:Perioperative dilutional coagulopathy was the important cause of perioperative bleeding.Prothrombin complex concentrates could supplement coagulation factors quickly and efficiently,improve coagulation function and reduce bleeding.It showed viral and thrombogenic safety although being a blood product.Conclusion:Several clinical researches suggest that prothrombin complex concentrates may be a good perioperative hemostatic agent.
作者 欧阳锡林
出处 《临床药物治疗杂志》 2017年第6期9-12,共4页 Clinical Medication Journal
关键词 稀释性凝血障碍 围术期凝血障碍 凝血酶原复合物 新鲜冰冻血浆 致栓性 dilutional coagulopathy perioperative coagulopathy prothrombin complex concentrates fresh frozen plasma thrombogenicity
  • 相关文献

参考文献5

二级参考文献58

  • 1余蓉,李晓红,祁辉,邬杨斌,曾蓉.批式吸附法制备人凝血因子Ⅸ复合物(英文)[J].中国现代应用药学,2003,20(6):450-452. 被引量:4
  • 2邱家山,徐琦,方为茂,钟本和.人凝血酶原复合物分离纯化工艺的研究进展[J].生物技术通报,2006,22(2):17-20. 被引量:4
  • 3TETZLAFFJ E, YOON H J, BELL G. Massive bleeding during spine surgery in a patient with ankylosing spondylitis[ J]. Can Anaesth, 1998, 45 (9) : 903 - 906.
  • 4CIAVARELLA D, REED R L, COUNTS R B, et al. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient [J]. Br J Haematol, 1987, 67(3) : 365 -368.
  • 5HIIPPALA S T. Replacement of massive blood loss[J]. Vox Sang, 1998, 74(Suppl 2) : 399 -407.
  • 6MURRAY D J, PENNELL B J, WEINSTEIN S L, et al. Packed red cells in acute blood loss: dilutional coagulopathy as a cause of surgical bleeding[J]. Anesth Analg, 1995, 80(2) : 336 -342.
  • 7FRIES D, KRISMER A, KLINGLER A, et al. Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model[ J]. Br J Anaesth, 2005, 95(2) : 172 - 177.
  • 8KHEIRABADI B S. Effects of synthetic versus natural colloid resuscitation on inducing dilutional coagulopathy and increasing hemorrhage in rabbits[J]. J Trauma, 21308, 64(5): 1 218-1 229.
  • 9MARKUS MITYERMAYRR. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery : the role of fibrinogen administration[J]. Anesth Analg, 2007, 105(4): 905 -917.
  • 10ARNAUD F, HAMMETT M, PHIBIN N, et al. Hematologic effects of recombinant factor Ⅶa combined with hemoglobin - based oxygen carrier -201 for prehospital resuscitation of swine with severe uncontrolled hemorrhage due to liver injury[ J ]. Blood Coagul Fibrinolysis, 2008, 19 (7) : 669 - 677.

共引文献59

同被引文献33

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部